Overview
Total raised
$39M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Nov 15, 2010 | Series C round | $24M |
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 30, 2024 | Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts | |
| Dec 26, 2023 | Daré Bioscience Secures $12 million in Royalty-backed Investment Structure | |
| Jul 31, 2023 | Daré Bioscience is given a $385K grant to conduct research on a new approach on idiopathic preterm birth | |
| Jun 29, 2016 | The biotech IPO feast flags as investors lose their appetite for R&D risk | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. But from 2013 through 2015 generalist investors got over their fears and jumped into one of the hottest stock games on the planet. Fund... |
| Feb 18, 2015 | Bessemer Looks Forward With New $1.6B Fund | Bessemer Venture Partners (BVP) announced its latest investment fund today with $1.6B in investments. It has dubbed it BVP IX. It follows a highly successful BVP VIII. Byron Deeter, a partner at BVP says this is just part of the normal fund... |
| Jan 22, 2015 | Bessemer Venture Partners 2014 Results Include 21 Exits, and Three IPOs | But They Don’t Always Get it Right: Established VC Kicks off 2015 by Updating List of Most Painful Misses MENLO PARK, Calif.–(BUSINESS WIRE)–January 22, 2015– Bessemer Venture Partners (BVP) – a global venture capital firm backing great ent... |
| Dec 15, 2011 | Cerulean Pharma Closes $15m Series D Financing | Cerulean Pharma Inc., a Cambridge, Massachusetts-based designer and developer of nanopharmaceuticals, has closed a $15m Series D financing. Backers include new investor, CVF, LLC, an affiliate of Henry Crown and Company of Chicago, Illinois... |
| Dec 15, 2011 | Cerulean Pharma Closes $15M Series D | CAMBRIDGE, MA, Leader in nanopharmaceuticals, announced that it has closed a $15M Series D financing with participation from new investor, CVF, as well as from all other existing investors Polaris, Venrock, Lilly Ventures, Lux Capital, an... |
| Nov 15, 2010 | Cerulean Pharma Closes $24M Series C Financing | Cerulean Pharma, Inc., a Cambridge, Massachusetts-based designer and developer of nanopharmaceuticals, has closed a $24m Series C financing. The round was led by Lilly Ventures, with participation from existing investors Polaris Venture Par... |
Show more
Reviews 0
FAQ about Cerulean Pharma
How much funding has Cerulean Pharma raised?
Cerulean Pharma has raised $39M in total across 2 funding rounds.
What funding rounds has Cerulean Pharma raised?
Parsers VC lists 2 funding rounds of Cerulean Pharma, among them a Series C round of $24M on Nov 15, 2010.
What has the press written about Cerulean Pharma?
Parsers VC has collected 11 articles mentioning Cerulean Pharma, among them “Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates throug...” (Apr 30, 2024) and “Daré Bioscience Secures $12 million in Royalty-backed Investment Structure” (Dec 26, 2023).
Is Cerulean Pharma still active?
Yes, Cerulean Pharma is active; its latest activity on Parsers VC dates from Dec 4, 2024.